San Carlos, United States
Dren Bio, Inc. is a Foster City, CA based biotechnology company, founded in 2019, focused on developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases. The company operates within the Biotechnology and Health Care industries with its headquarters in the United States.
The company has recently secured a significant Series B investment of $65.00M on 14 June 2022. The funding round saw participation from a notable group of investors including HBM Healthcare Investments, Aisling Capital, Alexandria Venture Investments, ArrowMark Partners, BVF Partners, HBM Partners, Mission BioCapital, Revelation Partners, SR One, and Taiho Ventures.
This successful investment round not only provides Dren Bio with the financial resources required for its continued growth and development but also signifies the confidence that prominent investors have in the company's innovative approach and potential impact within the biotechnology and healthcare sectors.
